BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Caliber Introduces Four AI-Powered Digital Solutions to Drive Pharma 4.0 Adoption

Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 r...

March 13, 2025 | News

Japan Grants Orphan Drug Designation to Lundbeck’s Amlenetug for Multiple System Atrophy

The Ministry of Health, Labor, and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck's investigational drug, amlenetu...

March 11, 2025 | News

SPRIM Global Investments and OneIM Launch $300M Joint Venture to Accelerate Clinical Trial Financing

SPRIM Global Investments ("SGI"), a global investment firm specializing in clinical-stage life sciences and pharma services based in Singapore, and On...

March 11, 2025 | News

Gan & Lee Initiates Phase 2 Trial of Bofanglutide, the First GLP-1 Mono-Agonist to Challenge Tirzepatide in Weight Management

Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced that the first participant has been successfully dosed in a P...

March 11, 2025 | News

Nona Biosciences Unveils AI-Powered Hu-mAtrIx™ Platform to Transform Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), announced to unveil its innovative AI-...

March 10, 2025 | News

RiboX Doses First Patient in Pioneering Circular RNA Therapy Trial for Radiation-Induced Xerostomia

RiboX Therapeutics Ltd. (RiboX), a pioneering biopharmaceutical company, focused on discovering and developing fully engineered circular RNA therapeutics,&...

March 10, 2025 | News

Merck Reports Strong 2024 Growth with €21.2 Billion in Sales, Projects Continued Expansion in 2025

Merck, a leading science and technology company, has delivered profitable growth in fiscal year 2024, demonstrating resilience and strategic execution acro...

March 07, 2025 | Company results

Suvoda Launches AI Assistant ‘Sofia’ to Enhance Clinical Trial Efficiency

Suvoda LLC, a global clinical trial technology company that specializes in complex studies in therapeutic areas like oncology, central nervous system...

March 06, 2025 | News

Frazier Life Sciences Launches Callio Therapeutics with $187M Series A to Advance Multi-Payload ADCs

Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from&nb...

March 05, 2025 | News

Celltrion Secures FDA Approval for STOBOCLO® and OSENVELT® as Biosimilars to PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA®&nbs...

March 05, 2025 | News

Elis Expands Cleanroom Solutions with Acquisition of BeMicron

Elis, the international multi-service provider for cleanroom, workwear, hygiene and facility services solutions, today announces the acquisition of 1...

March 05, 2025 | News

Elsevier Expands ClinicalKey AI with EHR and HIT Integrations to Enhance Clinician Workflows

Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company's leading generative ...

March 04, 2025 | News

MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform

MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...

March 04, 2025 | News

SmithRx Expands Connect 360 Autoimmune Program Adding Stelara Biosimilars and Partnering with Costco Specialty Pharmacy

SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), announced a major expansion to its Connect 360 Autoimmune Program, ...

March 03, 2025 | News

Stay Connected